tm logo
RYVIQARY
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 12 Nov 2024

Last Applicant/ Owned by

5301 Southwest Parkway, Bldg. 1, Suite 4

Austin

TX

78735

Serial Number

98359135 filed on 16th Jan 2024

Registration Number

N/A

Correspondent Address

Aaron D. Hendelman

Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI

Palo Alto, CA 94304

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

RYVIQARY

Pharmaceutical preparations based upon human allogeneic bone marrow mesenchymal stem cell derived extracellular vesicles (EVs) containing secretomes for the treatment of immunomodulatory, inflammatory, or autoimmune conditions such as respiratory diseases, neurological diseases, tissue injury and repair, gastrointestinal diseases, joint diseases and transplant.

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations based upon human allogeneic bone marrow mesenchymal stem cell derived extracellular vesicles (EVs) containing secretomes for the treatment of immunomodulatory, inflammatory, or autoimmune conditions such as respiratory diseases, neurological diseases, tissue injury and repair, gastrointestinal diseases, joint diseases and transplant.


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98359135

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 66309-TM1015

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
12th Nov 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
17th Sep 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17th Sep 2024PUBLISHED FOR OPPOSITION
28th Aug 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12th Aug 2024ASSIGNED TO EXAMINER
12th Aug 2024APPROVED FOR PUB - PRINCIPAL REGISTER
15th May 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
15th May 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15th May 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
10th May 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED